2025-11-24 - Analysis Report
Okay, let's break down the analysis of UnitedHealth Group Inc. (UNH) based on the data provided.

**1) Return Rate Comparison & Alpha/Beta Analysis**

*   **Company Overview:** UnitedHealth Group is a diversified health care company providing a wide range of health benefits and services.
*   **Return Comparison:** UNH's cumulative return is -18.65%, significantly underperforming the S&P 500 (VOO) which has a 94.64% return. The divergence between UNH and VOO is -113.3, and its relative divergence is 10.4.
*   **Analysis of Alpha/Beta Table:**
    *   The CAGR is decreasing (showing a decreasing stock) and MDD is very high (showing a risky stock).
    *   From 2015-2017 to 2023-2025, Alpha generally trends negative. A negative alpha suggests the stock is underperforming relative to the benchmark (S&P 500).
    *   Beta is volatile. Beta is generally above 0 (0 ~ 1.5) which means that it is sensitive to S&P 500.
    *   Market capitalization is decreasing.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** $319.97
*   **Last Market Data:** Price increased from 311.54 to 319.97 (change = +2.71)
*   **Moving Averages:**
    *   5-day SMA: $314.94
    *   20-day SMA: $330.93
    *   60-day SMA: $341.43
*   **Analysis:** The price closed above its 5-day SMA but below its 20-day and 60-day SMAs. This suggests a short-term upward trend, but it remains below medium-term and long-term averages. This could indicate a potential resistance level around the 20-day and 60-day SMAs.

**3) RSI, PPO, Divergence, and Expected Return**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 41.02 (Near neutral but trending towards oversold.)
*   **PPO:** -0.51 (Indicates the price is below its moving average, suggesting a downtrend).
*   **Hybrid Signal:** Sell 79.7% of holdings, indicates a bearish signal.
*   **Recent Divergence Change:** +2.3 (Short-term rise).
*   **Expected Return:** -153.5% (Very negative expectation, suggesting significant underperformance relative to the S&P 500 over a long-term horizon).
*   **Analysis:** The RSI is approaching oversold territory, which *could* signal a potential rebound. However, the PPO and expected return paint a negative picture.

**4) Recent News & Significant Events**

*   **Headlines Summary:**
    *   Several articles discuss the significant drop in UNH's stock price (over 38%).
    *   Some articles explore who owns the stock and potential buyback opportunities.
    *   One article questions whether UNH is an undervalued buy or not.
    *   One article highlight the strong outlook analysts watch closely
    *   One article mentions an AI analyst downgrade, although Wall Street isn't overly concerned.
    *   One article focuses on investor interest in UnitedHealth Group.
*   **Analysis:** The news is a mix of concern regarding the stock's recent decline and potential opportunities for investors. The focus on ownership and buybacks suggests potential value-seeking behavior.
4.  1.  **Analyst Opinions:**
*   **Consensus:** Buy (Mean of 2.00)
*   **Target Price:** Average target price of $386.72 (significantly higher than the current price).
*   **Recent Rating Changes:** No specific changes.
*   **Analysis:** While the consensus is still "Buy," the wide range in target prices ($198.00 - $440.00) suggests considerable uncertainty among analysts.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출         |
| ----------- | ----- | ----------- |
| 2025-10-28 | 2.59  | 113.16 B$ |
| 2025-08-11 | 3.76  | 111.62 B$ |
| 2025-05-07 | 6.9  | 109.58 B$ |
| 2024-11-04 | 6.56 | 100.82 B$ |
| 2025-10-28 | 6.56 | 100.82 B$ |

*   **Analysis:** The latest EPS is significantly lower than the previous quarters. Revenue is increasing consistently, but EPS is dropping. This could suggest rising costs or other factors impacting profitability.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue     | Profit Margin |
| ---------- | ----------- | ------------- |
| 2025-09-30 | $113.16B   | 18.24%        |
| 2025-06-30 | $111.62B   | 17.93%        |
| 2025-03-31 | $109.58B   | 21.70%        |
| 2024-12-31 | $100.81B   | 21.14%        |
| 2024-09-30 | $100.82B   | 22.84%        |

**Capital and Profitability:**

| Quarter    | Equity      | ROE   |
| ---------- | ----------- | ----- |
| 2025-09-30 | $95.79B   | 2.45% |
| 2025-06-30 | $94.72B   | 3.60% |
| 2025-03-31 | $95.04B   | 6.62% |
| 2024-12-31 | $92.66B   | 5.98% |
| 2024-09-30 | $94.53B   | 6.41% |

*   **Analysis:** While revenue is growing, the profit margin is decreasing.  ROE is also trending downwards, which indicates less profit relative to shareholders' equity.

**7) Comprehensive Analysis (Summary)**

UnitedHealth Group (UNH) is currently facing significant headwinds.

*   **Negative Performance:** The stock is underperforming the S&P 500 substantially.
*   **Deteriorating Financials:** EPS, profit margins and ROE are decreasing.
*   **Mixed Signals:** Technical indicators are giving mixed signals (RSI approaching oversold, but PPO negative).
*   **Negative Outlook:** Expected return is very negative.
*   **Analyst Uncertainty:** While the consensus remains "Buy", there's a wide range in target prices, indicating significant uncertainty. Recent news flow highlights concerns about the stock's recent decline.
*   **Investment Recommendation:** Based on the current data, a cautious approach is warranted. The "Sell" hybrid signal and negative expected return suggest potential further downside. Investors should closely monitor future earnings reports, news, and analyst sentiment before making any investment decisions.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.